Le Lézard
Classified in: Health
Subjects: NEW PRODUCTS/SERVICES, HEALTH, MISCELLANEOUS, Philanthropy

The Autism Speaks Canada Community Grants program is now accepting applications from organizations for 2023.


Toronto, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Autism Speaks Canada, a national charity dedicated to promoting solutions, across the spectrum and throughout the life span, has awarded over $4.8 million to 198 projects across the country since 2010.

 

Autism Speaks Canada's Community Grants are now open for submission. This year, the program has been structured to focus on addressing the social inclusion of autistic Canadians and their caregivers, specifically focusing on physical and emotional safety and community participation. The minimum award for each grant is $15,000 and the maximum award for each grant is $30,000. Grants are awarded through a rigorous review process, including a community panel of self-advocates, family members, friends, service providers, and research experts across Canada.

 

"We have aligned our 2023 Community Grants to match the current needs of autistic Canadians. We want to make a significant impact by supporting projects that increase the physical and emotional safety and security of autistic people. Autism Speaks Canada Community Grants is committed to supporting organizations providing access to supports and services across Canada." said Jill Farber the Executive Director at Autism Speaks Canada. The grants are meant to be responsive to the highest needs of our community and enhance the lives of autistic Canadians and their families. Autism Speaks Canada Community Grants will fund other charitable organizations. The deadline to apply is September 15, 2023.

 

About Autism Speaks Canada

Autism Speaks Canada is a national Canadian charity dedicated to promoting solutions, across the spectrum and throughout the life span.

Attachments



These press releases may also interest you

at 06:55
NovaBay® Pharmaceuticals, Inc. announces that it will report financial results for the three months ended March 31, 2024 after market close on Thursday, May 9, 2024 and will hold an investment community conference call that day beginning at 4:30...

at 06:50
Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell?based protein expression system, today...

at 06:17
Nationally recognized women's health advocate and former White House aide Alejandra Campoverdi will be Northeastern Illinois University's May 2024 Commencement speaker. Campoverdi is the bestselling author of "First Gen: A Memoir", which examines the...

at 06:10
Arcturis Data Limited ("Arcturis"), a UK leader in Real World Data and Evidence, and Oxford University Hospitals NHS Foundation Trust ("OUH") a global exemplar in clinical, research and digital health excellence, announce today that they are to...

at 05:45
The Gross Law Firm issues the following notice to shareholders of bluebird bio, Inc. . Shareholders who purchased shares of BLUE...

at 05:44
According to the latest BCC Research study, the demand for Pharmacy Automation: Technologies and Global Markets is growing from $7.8 billion in 2023 to $12.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 10.2% from 2023...



News published on and distributed by: